SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-043218
Filing Date
2013-05-20
Accepted
2013-05-20 17:01:27
Documents
11
Period of Report
2013-05-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-12528_28k.htm 8-K 28279
2 EX-99.1 a13-12528_2ex99d1.htm EX-99.1 59813
3 EX-99.2 a13-12528_2ex99d2.htm EX-99.2 167490
4 GRAPHIC g125282mmi001.jpg GRAPHIC 25473
5 GRAPHIC g125282mmi002.jpg GRAPHIC 17998
6 GRAPHIC g125282mmi003.jpg GRAPHIC 2107
7 GRAPHIC g125282mmi004.jpg GRAPHIC 2400
8 GRAPHIC g125282moi001.jpg GRAPHIC 28314
9 GRAPHIC g125282moi002.jpg GRAPHIC 19554
10 GRAPHIC g125282moi003.jpg GRAPHIC 2456
11 GRAPHIC g125282moi004.jpg GRAPHIC 2446
  Complete submission text file 0001104659-13-043218.txt   396742
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 13859095
SIC: 2834 Pharmaceutical Preparations